{"prompt": "['Tofacitinib', 'A3921284 NON-INTERVENTIONAL STUDY PROTOCOL', 'Amended, 12-December-2018', '5.', 'RESPONSIBLE PARTIES', 'Principal Investigator(s) of the Protocol', 'Name, degree(s)', 'Title', 'Affiliation', 'Address', 'PPD', ', PHARM, MSc', 'PPD', 'Pfizer', 'Colombia', 'PPD', 'MD, MSc', 'PPD', 'Pfizer', 'United States', 'PPD', ', MD', 'PPD', 'Pfizer', 'Peru', 'PPD', ',', 'DMD, MSc', 'PPD', 'Pfizer', 'Chile', 'PPD', ', MSc', 'PPD', 'Pfizer', 'Colombia', 'PPD', 'PPD', 'JSS Medical', 'Colombia', 'Research', 'PPD', 'PPD', 'JSS Medical', 'Colombia', 'Research', 'PPD', ', MD', 'PPD', 'JSS Medical', 'United States', 'Research', '5.1 CONTACTS', 'MEDICAL DIRECTION', 'Name/degree:', 'Dra. PPD', 'Contact phone:', 'PPD', 'Cell phone:', 'PPD', 'E-mail:', 'PPD', 'Address:', 'PPD', 'Name/degree:', 'Dr. PPD', 'Contact phone:', 'PPD', 'E-mail:', 'PPD', 'Address:', 'PPD', 'OPERATIONAL TEAM', 'Name/degree:', 'PPD', 'Contact phone:', 'PPD', 'Cell phone:', 'PPD', 'E-mail:', 'PPD', 'Address:', 'PPD', 'Page 10 of 64']['Tofacitinib', 'A3921284 NON-INTERVENTIONAL STUDY PROTOCOL', 'Amended, 12-December-2018', 'Name/degree:', 'PPD', 'Contact phone:', 'PPD', 'Cell phone:', 'PPD', 'E-mail:', 'PPD', 'Address:', 'PPD', 'Name/degree:', 'PPD', 'Contact phone:', 'PPD', 'E-mail:', 'PPD', 'Address:', 'PPD', 'Name/degree:', 'PPD', 'Contact phone:', 'PPD', 'Cell phone', 'PPD', 'Fax:', 'PPD', 'E-mail:', 'PPD', 'Address:', 'PPD', 'Adverse Event Reporting Contact:', 'Colombia', 'E-mail: PPD', 'DENTIAL', 'Phone: PPD', 'Cell phone: PPD', 'Peru - Ecuador', 'E-mail: PPD', 'Phone: PPD', 'Cell phone: PPD', 'Chile', 'E-mail:PPD', 'Phone: PPD', '*Contacts in charge of leading the project', 'Country Coordinating Investigators', 'The study is multicentric with multiple investigators', 'Page 11 of 64']['Tofacitinib', 'A3921284 NON-INTERVENTIONAL STUDY PROTOCOL', 'Amended, 12-December-2018', '6. FLOWCHART', 'Visit', 'Pre-visit*', 'Day 1', 'Day 180', 'Verification of inclusion criteria', 'Verification of exclusion criteria', 'Informed consent', 'Demographic data', 'Medical record', 'Current treatment', 'Clinical data', 'RAPID3 Measurement', 'EQ-5D Measurement', 'WPAI Measurement', 'Adapted HAQ-DI Measurement', 'Evaluation of adverse events identified through', 'medical record', 'Spontaneously reporting of adverse events by patient', 'Record for loss of follow-up', '*Criteria verification', 'CONFIDENTIAL', 'Page 12 of 64']\n\n###\n\n", "completion": "END"}